Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | ANKRD26 CL E G H | 22852 | 29186 | OMIM:188000 | THROMBOCYTOPENIA 2; THC2 | | | | 106 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | CALR CL E G H | 811 | 1455 | ORPHA:3318 | Essential thrombocythemia | | | | 1 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040282 - Frequent | | | 1 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | GATA1 CL E G H | 2623 | 4170 | ORPHA:67044 | Thrombocytopenia with congenital dyserythropoietic anemia | HP:0040281 - Very frequent | | | 29 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | | | | | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040283 - Occasional | | | 23 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040283 - Occasional | | | 21 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | | | | 3 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | JAK2 CL E G H | 3717 | 6192 | ORPHA:3318 | Essential thrombocythemia | | | | 57 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | JAK2 CL E G H | 3717 | 6192 | OMIM:263300 | Polycythemia vera | | | | 57 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040282 - Frequent | | | 57 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | JAK2 CL E G H | 3717 | 6192 | OMIM:614521 | Thrombocythemia 3 | | | | 57 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | KIF15 CL E G H | 56992 | 17273 | OMIM:619981 | | | | | | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | MPL CL E G H | 4352 | 7217 | OMIM:604498 | Amegakaryocytic thrombocytopenia, congenital | | | | 97 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | MPL CL E G H | 4352 | 7217 | ORPHA:3318 | Essential thrombocythemia | | | | 97 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040282 - Frequent | | | 97 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | MPL CL E G H | 4352 | 7217 | OMIM:601977 | THROMBOCYTHEMIA 2; THCYT2 | | | | 97 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | MYSM1 CL E G H | 114803 | 29401 | ORPHA:508542 | Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome | | | | | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | RFWD3 CL E G H | 55159 | 25539 | OMIM:617784 | Fanconi anemia, complementation group W | | | | | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | RPS14 CL E G H | 6208 | 10387 | OMIM:153550 | Chromosome 5q deletion syndrome | | | | | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | RPS14 CL E G H | 6208 | 10387 | ORPHA:86841 | Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality | HP:0040282 - Frequent | | | | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | SAMD9 CL E G H | 54809 | 1348 | OMIM:619041 | MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2; M7MLS2 | | | | 8 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | SF3B1 CL E G H | 23451 | 10768 | ORPHA:75564 | Acquired idiopathic sideroblastic anemia | HP:0040283 - Occasional | | | 19 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | SH2B3 CL E G H | 10019 | 29605 | ORPHA:3318 | Essential thrombocythemia | | | | 4 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | SLC35A1 CL E G H | 10559 | 11021 | ORPHA:238459 | SLC35A1-CDG | HP:0040281 - Very frequent | | | 24 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:75564 | Acquired idiopathic sideroblastic anemia | HP:0040283 - Occasional | | | 3 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:3318 | Essential thrombocythemia | | | | 3 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040282 - Frequent | | | 3 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:3318 | Essential thrombocythemia | | | | 911 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | UBA1 CL E G H | 7317 | 12469 | OMIM:301054 | VEXAS SYNDROME; VEXAS | | | | 35 | | |
HP:0012143 | HP:0012143 | Abnormal megakaryocyte morphology | 0 | ZNFX1 CL E G H | 57169 | 29271 | OMIM:619644 | IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91 | | | | | | |
HP:0012143 | HP:0031388 | Megakaryocyte nucleus hyperlobulation | 1 | CL E G H | | | | | | | | | | |
HP:0012143 | HP:0031387 | Increased multinucleated megakaryocyte count | 1 | CL E G H | | | | | | | | | | |
HP:0012143 | HP:0034010 | Increased megakaryocyte colony forming unit count | 1 | ANKRD26 CL E G H | 22852 | 29186 | OMIM:188000 | THROMBOCYTOPENIA 2; THC2 | | | | 106 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | CALR CL E G H | 811 | 1455 | ORPHA:3318 | Essential thrombocythemia | HP:0040281 - Very frequent | | | 1 | | |
HP:0012143 | HP:0005548 | Megakaryocytopenia | 1 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | HP:0040283 - Occasional | | | | | |
HP:0012143 | HP:0005548 | Megakaryocytopenia | 1 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | . | | | 3 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | JAK2 CL E G H | 3717 | 6192 | ORPHA:3318 | Essential thrombocythemia | HP:0040281 - Very frequent | | | 57 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | JAK2 CL E G H | 3717 | 6192 | OMIM:263300 | Polycythemia vera | . | | | 57 | | |
HP:0012143 | HP:0031386 | Increased micromegakaryocyte count | 1 | JAK2 CL E G H | 3717 | 6192 | OMIM:614521 | Thrombocythemia 3 | | | | 57 | | |
HP:0012143 | HP:0005548 | Megakaryocytopenia | 1 | KIF15 CL E G H | 56992 | 17273 | OMIM:619981 | | | | | | | |
HP:0012143 | HP:0005548 | Megakaryocytopenia | 1 | MPL CL E G H | 4352 | 7217 | OMIM:604498 | Amegakaryocytic thrombocytopenia, congenital | . | | | 97 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | MPL CL E G H | 4352 | 7217 | ORPHA:3318 | Essential thrombocythemia | HP:0040281 - Very frequent | | | 97 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | MPL CL E G H | 4352 | 7217 | OMIM:601977 | THROMBOCYTHEMIA 2; THCYT2 | | | | 97 | | |
HP:0012143 | HP:0031689 | Megakaryocyte dysplasia | 1 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0012143 | HP:0031689 | Megakaryocyte dysplasia | 1 | MYSM1 CL E G H | 114803 | 29401 | ORPHA:508542 | Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome | HP:0040282 - Frequent | | | | | |
HP:0012143 | HP:0031689 | Megakaryocyte dysplasia | 1 | RFWD3 CL E G H | 55159 | 25539 | OMIM:617784 | Fanconi anemia, complementation group W | | | | | | |
HP:0012143 | HP:0031385 | Megakaryocyte nucleus hypolobulation | 1 | RPS14 CL E G H | 6208 | 10387 | OMIM:153550 | Chromosome 5q deletion syndrome | | | | | | |
HP:0012143 | HP:0031385 | Megakaryocyte nucleus hypolobulation | 1 | RPS14 CL E G H | 6208 | 10387 | ORPHA:86841 | Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality | HP:0040282 - Frequent | | | | | |
HP:0012143 | HP:0031689 | Megakaryocyte dysplasia | 1 | SAMD9 CL E G H | 54809 | 1348 | OMIM:619041 | MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2; M7MLS2 | | | | 8 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | SF3B1 CL E G H | 23451 | 10768 | ORPHA:75564 | Acquired idiopathic sideroblastic anemia | HP:0040284 - Very rare | | | 19 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | SH2B3 CL E G H | 10019 | 29605 | ORPHA:3318 | Essential thrombocythemia | HP:0040281 - Very frequent | | | 4 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:75564 | Acquired idiopathic sideroblastic anemia | HP:0040284 - Very rare | | | 3 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:3318 | Essential thrombocythemia | HP:0040281 - Very frequent | | | 3 | | |
HP:0012143 | HP:0005513 | Increased megakaryocyte count | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:3318 | Essential thrombocythemia | HP:0040281 - Very frequent | | | 911 | | |
HP:0012143 | HP:0031689 | Megakaryocyte dysplasia | 1 | UBA1 CL E G H | 7317 | 12469 | OMIM:301054 | VEXAS SYNDROME; VEXAS | | | | 35 | | |
HP:0012143 | HP:0005548 | Megakaryocytopenia | 1 | ZNFX1 CL E G H | 57169 | 29271 | OMIM:619644 | IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91 | | | | | | |